MedTrace Logo

Long-term Survivorship of Discharged Patients With Malignant Tumor Based on Single-institutional Cancer Registry

NCT04996732 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 500000

Last updated 2021-08-09

No results posted yet for this study

Summary

Real-world studies on long-term prognosis in patients who underwent anti-tumor treatments during hospitalization from a hospital-based cancer registry in china.

Conditions

  • Neoplasms
  • Survival
  • Surgery
  • Radiotherapy
  • Drug Therapy

Interventions

PROCEDURE

hospitalization

Including various treatments such as surgery, radiotherapy, chemotherapy and immunotherapy during hospitalization

Sponsors & Collaborators

  • Fudan University

    lead OTHER

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2008-01-01
Primary Completion
2040-12-31
Completion
2041-12-31

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04996732 on ClinicalTrials.gov